Core Insights - The National Healthcare Security Administration has issued guidelines for pricing projects related to general treatment and pharmaceutical services, aiming to standardize and integrate existing price items [1] Group 1: General Treatment Pricing Guidelines - The guidelines for general treatment primarily adopt a method of transitioning existing projects, standardizing and integrating some overly detailed price items to ensure smooth connections [1] - To address the complexity and risks associated with treating pediatric patients, the guidelines introduce additional charges for certain price items such as injections, catheter placements, and gastric lavage, incentivizing healthcare institutions to enhance the quality of care for children [1] Group 2: Pharmaceutical Service Pricing Guidelines - The pharmaceutical service guidelines categorize services based on application scenarios, converting clearly defined patient needs and service contents into pricing projects, establishing 10 pricing items across four categories including pharmaceutical consultations and centralized configuration [1] - A unified outpatient consultation fee is established to encourage qualified pharmacists to provide scientific medication guidance through outpatient services [1] - A new home pharmaceutical service fee is introduced, allowing pharmacists to conduct home visits for medication assessment and guidance, with charges based on actual services provided, promoting the extension of pharmaceutical services to homebound patients, particularly benefiting the elderly and those with mobility issues [1]